View source for HYPERPARATHYROIDISM-PRIMARY, INVESTIGATION

===== [[Summary Article|'''SUMMARY''']] =====
1. Hypercalcemia + hypophosphatemia + raised PTH. 
<br/>
<br/>2. 25% of patient may have normal/high-normal PTH. <i>Normal patients will have suppressed PTH in the setting of hypercalcemia. </i> 
<br/>
<br/>3. Raised ALP: indicating increased bone resorption.
<br/>
<br/>4. Check 1,25-dehydroxychocecalciferol and replace if low.
<br/>
<br/>5. DDx: familial hypocalciuric hypercalcaemia.


==Reference(s)==
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. [https://amzn.to/3YHrI6K Get it on Amazon.]
<br/>Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. [https://amzn.to/3k7WSW0 Get it on Amazon.]
<br/>Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
<br/>Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].

[[Category:Hyperparathyroidism]]
[[Category:Endocrinology]]
[[Category:Medicine]]